• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus m2e with additional cysteine residues shows enhanced immunogenicity and protection against lethal virus challenge

tetano

Editor, Senior Moderator
Viral Immunol. 2013 Aug;26(4):291-5. doi: 10.1089/vim.2013.0001.
Influenza virus m2e with additional cysteine residues shows enhanced immunogenicity and protection against lethal virus challenge.
Kaminaka K, Matsuda J, Nozaki C.
Source

Applied Research Department, Kikuchi Research Center, The Chemo-sero-therapeutic Research Institute , Kikuchi-city, Kumamoto, Japan .
Abstract

Abstract The amino acid sequence of the extracellular domain of matrix protein 2 (M2e) is conserved among all subtypes of influenza A viruses. Therefore, the M2e peptide can be considered as a target antigen for the development of a universal influenza vaccine. We evaluated the effects of adding cysteine residues to a peptide of amino acids 2-24 of M2e. Mice immunized with some of these peptides containing one, two, three, four, or five extra cysteines displayed enhanced antibody titers to M2e. In addition, immunization with a peptide containing three extra cysteines, along with an aluminum adjuvant, protected mice more effectively against a lethal influenza virus challenge than the original M2e peptide. These results indicated that an M2e peptide containing additional cysteine residues could be a universal influenza vaccine candidate even without the addition of strong adjuvants.

PMID:
23941675
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23941675
 
Back
Top Bottom